mIHC assay shows high NEMO expression in the epidermis of PRP lesions in patients with KRT32 mutations compared with healthy individuals and PRP without KRT32 mutations (Supplementary Fig. 6), leading us to hypothesize that KRT32 may regulate NEMO expression. The gene discussed is KRT32; the disease is familial pityriasis rubra pilaris.